Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22:IV1–96. https://doi.org/10.1093/neuonc/noaa200.
Article PubMed PubMed Central Google Scholar
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.
Yarabarla V, Mylarapu A, Han TJ, McGovern SL, Raza SM, Beckham TH. Intracranial meningiomas: an update of the 2021 world health organization classifications and review of management with a focus on radiation therapy. Front Oncol. 2023. https://doi.org/10.3389/fonc.2023.1137849.
Article PubMed PubMed Central Google Scholar
Preusser M, Brastianos PK, Mawrin C. Advances in meningioma genetics: novel therapeutic opportunities. Nat Rev Neurol. 2018;14:106–15. https://doi.org/10.1038/nrneurol.2017.168.
Article PubMed CAS Google Scholar
Youngblood MW, Günel M. Molecular genetics of meningiomas. In: Handbook of clinical neurology. Amsterdam: Elsevier BV; 2020. p. 101–19.
Pü Ttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, Paulus W. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest. 2005;85:1163–71. https://doi.org/10.1038/labinvest.3700307.
Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, Dunn IF. Genomic profile of human meningioma cell lines. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0178322.
Article PubMed PubMed Central Google Scholar
Kim E, Kim M, So K, Park YS, Woo CG, Hyun SH. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors. Cancer Cell Int. 2020;20:1–15. https://doi.org/10.1186/S12935-020-01438-X/TABLES/3.
Talabnin C, Trasaktaweesakul T, Jaturutthaweechot P, Asavaritikrai P, Kongnawakun D, Silsirivanit A, Araki N, Talabnin K. Altered O-linked glycosylation in benign and malignant meningiomas. PeerJ. 2024. https://doi.org/10.7717/peerj.16785.
Article PubMed PubMed Central Google Scholar
Naradun N, Talabnin K, Ayuttha KI, Talabnin C. Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death. Naunyn Schmiedebergs Arch Pharmacol. 2023;396:109–20. https://doi.org/10.1007/s00210-022-02305-4.
Article PubMed CAS Google Scholar
Malek K, Wood BR, Bambery KR. FTIR imaging of tissues: techniques and methods of analysis. In: Challenges and advances in computational chemistry and physics. New York: Springer; 2014. p. 419–73.
Adorni MP, Galetti M, La Monica S, Incerti M, Ruffoni A, Elviri L, Zanotti I, Papotti B, Cavallo D, Alfieri R, Petronini PG, Bernini F. A new ABCB1 inhibitor enhances the anticancer effect of doxorubicin in both in vitro and in vivo models of NSCLC. Int J Mol Sci. 2023;24:989. https://doi.org/10.3390/ijms24020989.
Article PubMed PubMed Central CAS Google Scholar
Pettersson-Segerlind J, Orrego A, Lönn S, Mathiesen T. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg. 2011;76(6):564–71.
Shivapathasundram G, Wickremesekera AC, Tan ST, Itinteang T. Tumour stem cells in meningioma: a review. J Clin Neurosci. 2018;47:66–71. https://doi.org/10.1016/j.jocn.2017.10.059.
Article PubMed CAS Google Scholar
Hueng DY, Sytwu HK, Huang SM, Chang C, Ma HI. Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol. 2011;104:45–53. https://doi.org/10.1007/s11060-010-0469-1.
Article PubMed CAS Google Scholar
Rath P, Miller DC, Litofsky NS, Anthony DC, Feng Q, Franklin C, Pei L, Free A, Liu J, Ren M, Kirk MD, Shi H. Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol. 2011;90:179–88. https://doi.org/10.1016/j.yexmp.2010.12.003.
Article PubMed CAS Google Scholar
Freitag D, McLean AL, Simon M, Koch A, Grube S, Walter J, Kalff R, Ewald C. NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades. Mol Carcinog. 2017;56:1953–64. https://doi.org/10.1002/mc.22653.
Article PubMed CAS Google Scholar
Di Bonaventura R, Martini M, Cenci T, Caccavella VM, Barresi V, Gessi M, Albanese A, Lauretti L, Pallini R, D’Alessandris QG, Olivi A. Dissecting stemness in aggressive intracranial meningiomas: prognostic role of SOX2 expression. Int J Mol Sci. 2022;23:11690. https://doi.org/10.3390/ijms231911690.
Article PubMed PubMed Central CAS Google Scholar
Kökoǧlu E, Görseval A, Sönmez H, Özyurt E. Tissue lipid composition of human gliomas and meningiomas. Cancer Lett. 1992;65:169–71. https://doi.org/10.1016/0304-3835(92)90162-O.
Li L, Bi X, Sun H, Liu S, Yu M, Zhang Y, Weng S, Yang L, Bao Y, Wu J, Xu Y, Shen K. Characterization of ovarian cancer cells and tissues by Fourier transform infrared spectroscopy. J Ovarian Res. 2018. https://doi.org/10.1186/s13048-018-0434-8.
Article PubMed PubMed Central Google Scholar
Shiomi K, Kiyono T, Okamura K, Uezumi M, Goto Y, Yasumoto S, Shimizu S, Hashimoto N. CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential. Gene Ther. 2011;18:857–66. https://doi.org/10.1038/gt.2011.44.
Comments (0)